![USPTO issues two new patents to Cellectis for TAL-effector nuclease USPTO issues two new patents to Cellectis for TAL-effector nuclease](http://www.biofuelsdigest.com/bdigest/wp-content/themes/wp-ellie204/images/def-thumb2.jpg)
USPTO issues two new patents to Cellectis for TAL-effector nuclease
In Minnesota, Cellectis, a genome engineering specialist, announced the issuance by the USPTO on May 14th, 2013 of two new US patents (US 8,440,431 and US 8,440,432) directed to TAL-effector nucleases. The molecules produced by Cellectis have been distributed to prestigious laboratories over the world under the trademark TALEN. The inventors of both patents are […]